Looking for CALR mutations in familial myeloproliferative neoplasms

Leukemia. 2014 Jun;28(6):1357-60. doi: 10.1038/leu.2014.33. Epub 2014 Jan 20.

Authors

M Maffioli¹, A Genoni², D Caramazza¹, B Mora¹, A Bussini², M Merli¹, T Giorgino³, R Casalone², F Passamonti¹

Affiliations

¹ Division of Hematology, Department of Medicine, University Hospital Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
² Genetic Unit, Medical Genetic and Cytogenetics Laboratory, SSD, SMEL, University Hospital Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
³ Institute of Biomedical Engineering, National Research Council of Italy (ISIB-CNR), Padua, Italy.

PMID: 24441291
DOI: 10.1038/leu.2014.33

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Calreticulin / genetics*
Female
Genetic Predisposition to Disease*
Humans
Janus Kinase 2 / genetics*
Male
Middle Aged
Mutation / genetics*
Myeloproliferative Disorders / genetics*
Pedigree
Prognosis
Young Adult

Substances

CALR protein, human
Calreticulin
JAK2 protein, human
Janus Kinase 2